Inventor · disambiguated record
Ralph Schwall
Also filed as: SCHWALL RALPH · SCHWALL RALPH H
18 granted patents·31 pending applications·1,823 citations·filing 1994–2019
97Inventor score
Top patents by PatentIndex Score
49 records- 0198US8142784B2Antibody-drug conjugates and methodsEBENS JR ALLEN J·Filed 2008·Granted Mar 27, 2012·123 cites·6 claims
- 0298US7575748B1Methods of treatment using anti-ErbB antibody-maytansinoid conjugatesGENENTECH INC·Filed 2006·Granted Aug 18, 2009·104 cites·27 claims
- 0398US7097840B2Methods of treatment using anti-ErbB antibody-maytansinoid conjugatesIMMUNOGEN INC·Filed 2001·Granted Aug 29, 2006·266 cites·44 claims
- 0498US6468529B1Hepatocyte growth factor receptor antagonists and uses thereofGENENTECH INC·Filed 2000·Granted Oct 22, 2002·238 cites·25 claims
- 0598US5686292AHepatocyte growth factor receptor antagonist antibodies and uses thereofGENENTECH INC·Filed 1995·Granted Nov 11, 1997·295 cites·14 claims
- 0697US6632979B2Rodent HER2 tumor modelGENENTECH INC·Filed 2001·Granted Oct 14, 2003·170 cites·37 claims
- 0796US6207152B1Hepatocyte growth factor receptor antagonists and uses thereofGENENTECH INC·Filed 1996·Granted Mar 27, 2001·126 cites·19 claims
- 0893US8652479B2Antibody-drug conjugates and methodsEBENS JR ALLEN J·Filed 2008·Granted Feb 18, 2014·25 cites·12 claims
- 0992US6214344B1Hepatocyte growth factor receptor antagonists and uses thereofGENENTECH INC·Filed 1998·Granted Apr 10, 2001·119 cites·16 claims
- 1092US6099841AHepatocyte growth factor receptor agonists and uses thereofGENENTECH INC·Filed 1997·Granted Aug 8, 2000·101 cites·29 claims
- 1188US5646036ANucleic acids encoding hepatocyte growth factor receptor antagonist antibodiesGENENTECH INC·Filed 1995·Granted Jul 8, 1997·66 cites·12 claims
- 1285US6133231AAngiogenesis using hepatocyte growth factorGENENTECH INC·Filed 1998·Granted Oct 17, 2000·50 cites·7 claims
- 1385US5464815AInhibition of heparin-bindingGENENTECH INC·Filed 1994·Granted Nov 7, 1995·67 cites·27 claims
- 1471US2009148457A1Hepatocyte growth factor receptor antagonists and uses thereofGENENTECH INC·Filed 2009·Application pending·0 cites
- 1570US2014212411A1Methods of treatment using anti-erbb antibody-maytansinoid conjugatesSCHWALL GAIL COLBERN·Filed 2013·Application pending·0 cites
- 1669US5703048AProtection against liver damage by HGFGENENTECH INC·Filed 1995·Granted Dec 30, 1997·19 cites·15 claims
- 1767US2008200375A1Angiogenesis using hepatocyte growth factorST ELIZABETH S MEDICAL CT OF B·Filed 2006·Application pending·0 cites
- 1867US2005227324A1Monovalent antibody fragments useful as therapeuticsGENENTECH INC·Filed 2004·Application pending·0 cites
- 1966US5849689AMethod of extending the plasma half-life of deletion variants of hepatocyte growth factorGENENTECH INC·Filed 1995·Granted Dec 15, 1998·22 cites·23 claims
- 2066US2006211612A1Angiogenesis using hepatocyte growth factorGENENTECH INC·Filed 2005·Application pending·0 cites
- 2166US2010136033A1METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATESIMMUNOGEN INC·Filed 2009·Application pending·0 cites
- 2266US2014056921A1Hepatocyte Growth Factor Receptor Antagonists and Uses ThereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 2366US2017106097A1Methods of treatment using anti-erbb antibody maytansinoid conjugatesIMMUNOGEN INC·Filed 2016·Application pending·0 cites
- 2464US2005089958A1Apo-2 ligandGENENTECH INC·Filed 2003·Application pending·0 cites
- 2563US2015110816A1Methods of treatment using anti-erbb antibody-maytansinoid conjugatesIMMUNOGEN INC·Filed 2014·Application pending·0 cites
- 2663US2014205593A1Monovalent antibody fragments useful as therapeuticsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2762US2009041788A1Apo-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2008·Application pending·0 cites
- 2862US2009186812A1Apo-2 ligandGENENTECH INC·Filed 2006·Application pending·0 cites
- 2961US2011183916A1Apo-2 LigandGENENTECH INC·Filed 2010·Application pending·0 cites
- 3061US2008063641A1Monovalent antibody fragments useful as therapeuticsHUANG ARTHUR J·Filed 2006·Application pending·0 cites
- 3160US2016222115A1Monovalent antibody fragments useful as therapeuticsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3260US2014128580A1Antibody-drug conjugates and methodsGENENTECH INC·Filed 2014·Application pending·0 cites
- 3359US5654404AProtection against liver damage by HGFGENENTECH INC·Filed 1995·Granted Aug 5, 1997·20 cites·18 claims
- 3459US2008176788A1Apo-2 ligandGENENTECH INC·Filed 2005·Application pending·0 cites
- 3559US2008044415A1Hepatocyte growth factor receptor antagonists and uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
- 3657US2011200596A1Monovalent antibody fragments useful as therapeuticsGENENTECH INC·Filed 2011·Application pending·0 cites
- 3757US2013108620A1Methods of treatment using anti-erbb antibody-maytansinoid conjugatesBLATTLER WALTER·Filed 2011·Application pending·0 cites
- 3857US2007026000A1APO-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2006·Application pending·0 cites
- 3957US2011280870A1Hepatocyte growth factor receptor antagonists and uses thereofSCHWALL RALPH H·Filed 2011·Application pending·0 cites
- 4056US2005276812A1Antibody-drug conjugates and methodsGENENTECH INC·Filed 2005·Application pending·0 cites
- 4155US2005250686A1Angiogenesis using hepatocyte growth factorFERRARA NAPOLEONE·Filed 2003·Application pending·0 cites
- 4255US2004228868A1Apo-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2004·Application pending·0 cites
- 4353US2012321628A1Hepatocyte growth factor receptor antagonists and uses thereofSCHWALL RALPH H·Filed 2012·Application pending·0 cites
- 4452US2020048362A1Methods of treatment using anti-erbb antibody-maytansinoid conjugatesIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 4549US5851989AMethod of extending the plasma half-life of vascular endothelial cell growth factorGENENTECH INC·Filed 1995·Granted Dec 22, 1998·9 cites·14 claims
- 4649US2002136721A1Hepatocyte growth factor receptor antagonists and uses thereofFiled 2001·Application pending·0 cites
- 4744US2006177448A1Inhibiting HER2 shedding with matrix metalloprotease antagonistsGENENTECH INC·Filed 2006·Application pending·0 cites
- 4842US2003118587A1Hepatocyte growth factor receptor antagonists and uses thereofFiled 2002·Application pending·0 cites
- 4932US6133234AMethods and compositions for treating vascular stenosisGENENTECH INC·Filed 1998·Granted Oct 17, 2000·3 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Ralph Schwall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →